ROC-0929
| Code | Size | Price |
|---|
| TAR-T38446-10mg | 10mg | £870.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
ROC-0929 (compound 13a) is a potent and selective inhibitor of secreted phospholipases A 2 (sPLA 2 s) with an IC 50 of 80 nM, specially targeting hGX . ROC-0929 inhibits the phosphorylation of ERK1/2 and p-38 . Secreted phospholipases A2 (sPLA2s) are a family of disulfide-rich, Ca 2+ -dependent enzymes that hydrolyze the sn-2 position of glycero-phospholipids to release a fatty acid and a lysophospholipid. ROC-0929 has the potential for researching inflammation related diseases.
CAS:
1048660-43-0
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Hallstrand TS, et al. Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils. J Allergy Clin Immunol. 2016;137(1):268-277.e8.
Oslund RC, et al. Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. J Med Chem. 2008;51(15):4708-4714.